Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Journal of Clinical Oncology
Gregory W.Roloff
IbrahimAldoss
Noam E.Kopmar
ChenyuLin
Simone E.Dekker
Vishal K.Gupta
Timothy E.O’Connor
NikeshanJeyakumar
Ibrahim N.Muhsen
YannisValtis
NaveedAhmed
AmyZhang
KatharineMiller
Kaitlyn C.Dykes
MohamedAhmed
Evan C.Chen
SantiagoMercadal
MarcSchwartz
Sean I.Tracy
BhagirathbhaiDholaria
AkashMukherjee
MinooBattiwalla
Aaron C.Logan
AbdullahLadha
CaitlinGuzowski
Rasmus T.Hoeg
TalalHilal
JozalMoore
Matthew P.Connor
La Quisa C.Hill
Stephanie B.Tsai
Joshua P.Sasine
Melhem M.Solh
Vamsi K.Kota
DivyaKoura
MuthuVeeraputhiran
Jessica T.Leonard
Noelle V.Frey
Jae H.Park
Marlise R.Luskin
VeronikaBachanova
AhmedGalal
VinodPullarkat
WendyStock
Ryan D.Cassaday
Bijal D.Shah
RawanFaramand
LoriMuffly
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
SomyaKhare
StaciWilliamson
BrittanyO'Barr
LevantoSchachter
AndyChen
BrandonHayes-Lattin
JessicaLeonard
AmritaDesai
PeterFerreira-Gandolfo
KevinChristmas
DeniseLackey
Richard T.Maziarz
Eneida R.Nemecek
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Blood Advances
IbrahimAldoss
Gregory W.Roloff
RawanFaramand
Noam E.Kopmar
ChenyuLin
Anjali S.Advani
Simone E.Dekker
Vishal K.Gupta
Timothy E.O’Connor
NikeshanJeyakumar
Ibrahim N.Muhsen
YannisValtis
AmyZhang
KatharineMiller
KatherineSutherland
Kaitlyn C.Dykes
MohamedAhmed
EvanChen
HectorZambrano
DanielleBradshaw
SantiagoMercadal
MarcSchwartz
SeanTracy
BhagirathbhaiDholaria
MichalKubiak
AkashMukherjee
NavneetMajhail
MinooBattiwalla
LukeMountjoy
Shahbaz A.Malik
JohnMathews
PaulShaughnessy
Aaron C.Logan
AbdullahLadha
MaryannStefan
CaitlinGuzowski
Rasmus T.Hoeg
TalalHilal
JozalMoore
MatthewConnor
Kristen M.O’Dwyer
La Quisa C.Hill
Stephanie B.Tsai
JoshuaSasine
Melhem M.Solh
Catherine J.Lee
Vamsi K.Kota
DivyaKoura
MuthuVeeraputhiran
BetsyBlunk
CaspianOliai
Jessica T.Leonard
Noelle V.Frey
Jae H.Park
Marlise R.Luskin
VeronikaBachanova
AhmedGalal
Michael R.Bishop
WendyStock
Ryan D.Cassaday
VinodPullarkat
Bijal D.Shah
Lori S.Muffly
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
JAMA
EliasJabbour
Hagop M.Kantarjian
IbrahimAldoss
PauMontesinos
Jessica T.Leonard
DavidGómez-Almaguer
Maria R.Baer
CarloGambacorti-Passerini
JamesMcCloskey
YosukeMinami
CristinaPapayannidis
VandersonRocha
PhilippeRousselot
PankitVachhani
Eunice S.Wang
BingxiaWang
MeliessaHennessy
AlexanderVorog
NitiPatel
TammieYeh
Jose MariaRibera
Thromboprophylaxis with intermediate dose enoxaparin during asparaginase containing induction for young adults with acute lymphoblastic leukemia
Leukemia and Lymphoma
HongDe Sa
ThomasDeloughery
AndyKaempf
CurtisLachowiez
JessicaLeonard
RickMathews
ShaunaRakshe
Joseph J.Shatzel
RonanSwords
ElieTraer
BrandonHayes-Lattin
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
Blood Advances
Curtis A.Lachowiez
NicolaLong
JenniferSaultz
ArpitaGandhi
Laura F.Newell
BrandonHayes-Lattin
Richard T.Maziarz
JessicaLeonard
DanielBottomly
ShannonMcWeeney
JenniferDunlap
RichardPress
GabrielleMeyers
RonanSwords
Rachel J.Cook
Jeffrey W.Tyner
Brian J.Druker
ElieTraer
Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
Blood Advances
Emily C.Liang
Simone E.Dekker
Jean M.G.Sabile
StefanTorelli
AmyZhang
KatharineMiller
ParveenShiraz
BrandonHayes-Lattin
Jessica T.Leonard
LoriMuffly
PSEUDOPANUVEITIS AS A HARBINGER for SYSTEMIC LEUKEMIA RECURRENCE
Retinal Cases and Brief Reports
Marcus T.Altman
ZaneStaubach
JenniferDunlap
AmrZaki
Alison H.Skalet
JessicaLeonard
PhoebeLin
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Cancer Cell
DanielBottomly
NicolaLong
Anna ReisterSchultz
Stephen E.Kurtz
Cristina E.Tognon
KaraJohnson
MelissaAbel
AnupriyaAgarwal
SammanthaAvaylon
ErikBenton
AuroraBlucher
UmaBorate
Theodore P.Braun
JordanaBrown
JadeBryant
RussellBurke
AmyCarlos
Bill H.Chang
Hyun JunCho
StephenChristy
CodyCoblentz
Aaron M.Cohen
Amandad'Almeida
RachelCook
AlexeyDanilov
Kim Hien T.Dao
MichieDegnin
JamesDibb
Christopher A.Eide
IsabelEnglish
StuartHagler
HeathHarrelson
RachelHenson
HiberyHo
Sunil K.Joshi
BrianJunio
AndyKaempf
YokoKosaka
TedLaderas
MattLawhead
HyunjungLee
Jessica T.Leonard
ChenweiLin
Evan F.Lind
Selina QiuyingLiu
PierretteLo
Marc M.Loriaux
SamuelLuty
Julia E.Maxson
TaraMacey
JacquelineMartinez
JessicaMinnier
AndreaMonteblanco
MotomiMori
QuinlanMorrow
DylanNelson
JustinRamsdill
AngelaRofelty
AlexandraRogers
Kyle A.Romine
PeterRyabinin
Jennifer N.Saultz
David A.Sampson
Samantha L.Savage
RobertSchuff
RobertSearles
Rebecca L.Smith
Stephen E.Spurgeon
TylerSweeney
Ronan T.Swords
AashisThapa
KarinaThiel-Klare
ElieTraer
JakeWagner
BethWilmot
JoelleWolf
GuanmingWu
AmyYates
HaijiaoZhang
Christopher R.Cogle
Robert H.Collins
Michael W.Deininger
Christopher S.Hourigan
Craig T.Jordan
Tara L.Lin
Micaela E.Martinez
Rachel R.Pallapati
Daniel A.Pollyea
Anthony D.Pomicter
Justin M.Watts
Scott J.Weir
Brian J.Druker
Shannon K.McWeeney
Jeffrey W.Tyner
Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL
Blood
Jessica T.Leonard
YokoKosaka
PavaniMalla
DorianLaTocha
AdamLamble
BrandonHayes-Lattin
KaelanByrd
Brian J.Druker
Jeffrey W.Tyner
Bill H.Chang
EvanLind
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse
Transplantation and Cellular Therapy
Laura F.Newell
ToddWilliams
JamesLiu
YunYu
YiyiChen
Georgeann C.Booth
Rebekah J.Knight
Kelli R.Goslee
Rachel J.Cook
JessicaLeonard
GabrielleMeyers
ElieTraer
Richard D.Press
GuangFan
YingWang
Philipp W.Raess
Richard T.Maziarz
JenniferDunlap
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations
American Journal of Transplantation
Laura F.Newell
JenniferDunlap
KenGatter
Grover C.Bagby
Richard D.Press
Rachel J.Cook
LukeFletcher
Jessica T.Leonard
Kelli M.Leong
Joseph S.Bubalo
AliOlyaei
Thomas G.Deloughery
Richard T.Maziarz
ErinMaynard
Susan L.Orloff
C. KristianEnestvedt
Venetoclax and navitoclax in combination with chemotherapy in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma
Cancer discovery
Vinod A.Pullarkat
Norman J.Lacayo
EliasJabbour
Jeffrey E.Rubnitz
AshishBajel
Theodore W.Laetsch
JessicaLeonard
Susan I.Colace
Seong LinKhaw
Shaun A.Fleming
Ryan J.Mattison
RobinNorris
Joseph T.Opferman
Kathryn G.Roberts
YaqiZhao
ChunxuQu
MohamedBadawi
MichelleSchmidt
BoTong
John C.Pesko
YanSun
Jeremy A.Ross
DeekshaVishwamitra
LindseyRosenwinkel
Su YoungKim
AmandaJacobson
Charles G.Mullighan
Thomas B.Alexander
WendyStock
Functional characterization of two rare BCR-FGFR1+ leukemias
Cold Spring Harbor Molecular Case Studies
Evan J.Barnes
JessicaLeonard
Bruno C.Medeiros
Brian J.Druker
Cristina E.Tognon
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
Hematology/ Oncology and Stem Cell Therapy
CurtisLachowiez
Rachel J.Cook
BrandonHayes-Lattin
Richard T.Maziarz
UmaBorate
ElieTraer
JessicaLeonard
LauraNewell
Kim HienDao
GabrielleMeyers
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
American Journal of Hematology
Jennifer B.Dunlap
JessicaLeonard
MaraRosenberg
RachelCook
RichardPress
GuangFan
Philipp W.Raess
Brian J.Druker
ElieTraer
Functional genomic landscape of acute myeloid leukaemia
Nature
Jeffrey W.Tyner
Cristina E.Tognon
DanielBottomly
BethWilmot
Stephen E.Kurtz
Samantha L.Savage
NicolaLong
Anna ReisterSchultz
ElieTraer
MelissaAbel
AnupriyaAgarwal
AuroraBlucher
UmaBorate
JadeBryant
RussellBurke
AmyCarlos
RichieCarpenter
JosephCarroll
Bill H.Chang
CodyCoblentz
Amandad’Almeida
RachelCook
AlexeyDanilov
Kim Hien T.Dao
MichieDegnin
DeirdreDevine
JamesDibb
David K.Edwards
Christopher A.Eide
IsabelEnglish
JasonGlover
RachelHenson
HiberyHo
AbduseburJemal
KaraJohnson
RyanJohnson
BrianJunio
AndyKaempf
JessicaLeonard
ChenweiLin
Selina QiuyingLiu
PierretteLo
Marc M.Loriaux
SamuelLuty
TaraMacey
JasonMacManiman
JacquelineMartinez
MotomiMori
DylanNelson
CeilidhNichols
JillPeters
JustinRamsdill
AngelaRofelty
RobertSchuff
RobertSearles
ErikSegerdell
Rebecca L.Smith
Stephen E.Spurgeon
TylerSweeney
AashisThapa
CorinneVisser
JakeWagner
KevinWatanabe-Smith
KristenWerth
JoelleWolf
LibbeyWhite
AmyYates
HaijiaoZhang
Christopher R.Cogle
Robert H.Collins
Denise C.Connolly
Michael W.Deininger
LeylahDrusbosky
Christopher S.Hourigan
Craig T.Jordan
PatriciaKropf
Tara L.Lin
Micaela E.Martinez
Bruno C.Medeiros
Rachel R.Pallapati
Daniel A.Pollyea
Ronan T.Swords
Justin M.Watts
Scott J.Weir
David L.Wiest
Ryan M.Winters
Shannon K.McWeeney
Brian J.Druker
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma
Leukemia and Lymphoma
Andy I.Chen
Jessica T.Leonard
Craig Y.Okada
Nathan D.Gay
KariChansky
GuangFan
Jennifer B.Dunlap
Philipp W.Raess
Rita M.Braziel
AlexStentz
Richard T.Maziarz
Progress in adult ALL
Hematology
JessicaLeonard
WendyStock
Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
Journal of Hematology and Oncology
Jessica T.Leonard
Philipp W.Raess
JenniferDunlap
BrandonHayes-Lattin
Jeffrey W.Tyner
ElieTraer
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia
Science translational medicine
Jessica T.Leonard
Joelle S.J.Rowley
Christopher A.Eide
ElieTraer
BrandonHayes-Lattin
MarcLoriaux
Stephen E.Spurgeon
Brian J.Druker
Jeffrey W.Tyner
Bill H.Chang
Chronic GvHD-associated serositis and pericarditis